Nautilus Biotechnology, Inc. NAUT
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -- | -1.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -- | -1.06% | |||
| Operating Income | -- | 2.24% | |||
| Income Before Tax | -- | 1.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -- | 1.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -- | 1.55% | |||
| EBIT | -- | 2.24% | |||
| EBITDA | -- | 1.89% | |||
| EPS Basic | -8.00% | 1.98% | |||
| Normalized Basic EPS | -8.02% | 1.93% | |||
| EPS Diluted | -8.00% | 1.98% | |||
| Normalized Diluted EPS | -8.02% | 1.93% | |||
| Average Basic Shares Outstanding | 0.08% | 0.40% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||